Grassmann André Alex, Kremer Frederico Schmitt, Dos Santos Júlia Cougo, Souza Jéssica Dias, Pinto Luciano da Silva, McBride Alan John Alexander
Biotechnology Unit, Technological Development Center, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Ministry of Health, Salvador, Bahia, Brazil.
Front Immunol. 2017 Apr 27;8:463. doi: 10.3389/fimmu.2017.00463. eCollection 2017.
spp. are diderm (two membranes) bacteria that infect mammals causing leptospirosis, a public health problem with global implications. Thousands of people die every year due to leptospirosis, especially in developing countries with tropical climates. Prophylaxis is difficult due to multiple factors, including the large number of asymptomatic hosts that transmit the bacteria, poor sanitation, increasing numbers of slum dwellers, and the lack of an effective vaccine. Several leptospiral recombinant antigens were evaluated as a replacement for the inactivated (bacterin) vaccine; however, success has been limited. A prospective vaccine candidate is likely to be a surface-related protein that can stimulate the host immune response to clear leptospires from blood and organs. In this study, a comprehensive bioinformatics approach based on reverse and structural vaccinology was applied toward the discovery of novel leptospiral vaccine candidates. The serovar Copenhageni strain L1-130 genome was mined for the enhanced identification of conserved β-barrel (βb) transmembrane proteins and outer membrane (OM) lipoproteins. Orthologs of the prospective vaccine candidates were screened in the genomes of 20 additional spp. Three-dimensional structural models, with a high degree of confidence, were created for each of the surface-exposed proteins. Major histocompatibility complex II (MHC-II) epitopes were identified, and their locations were mapped on the structural models. A total of 18 βb transmembrane proteins and 8 OM lipoproteins were identified. These proteins were conserved among the pathogenic spp. and were predicted to have epitopes for several variants of MHC-II receptors. A structural and functional analysis of the sequence of these surface proteins demonstrated that most βb transmembrane proteins seem to be TonB-dependent receptors associated with transportation. Other proteins identified included, e.g., TolC efflux pump proteins, a BamA-like OM component of the βb transmembrane protein assembly machinery, and the LptD-like LPS assembly protein. The structural mapping of the immunodominant epitopes identified the location of conserved, surface-exposed, immunogenic regions for each vaccine candidate. The proteins identified in this study are currently being evaluated for experimental evidence for their involvement in virulence, disease pathogenesis, and physiology, in addition to vaccine development.
钩端螺旋体属细菌是双膜细菌,可感染哺乳动物,引发钩端螺旋体病,这是一个具有全球影响的公共卫生问题。每年有数千人死于钩端螺旋体病,尤其是在热带气候的发展中国家。由于多种因素,预防工作困难重重,包括大量传播细菌的无症状宿主、卫生条件差、贫民窟居民数量增加以及缺乏有效的疫苗。几种钩端螺旋体重组抗原被评估作为灭活(菌苗)疫苗的替代品;然而,成效有限。一种有前景的候选疫苗可能是一种与表面相关的蛋白质,它能刺激宿主免疫反应,从血液和器官中清除钩端螺旋体。在本研究中,基于反向和结构疫苗学的综合生物信息学方法被用于发现新型钩端螺旋体疫苗候选物。对哥本哈根血清型菌株L1 - 130的基因组进行挖掘,以增强对保守的β - 桶(βb)跨膜蛋白和外膜(OM)脂蛋白的鉴定。在另外20种钩端螺旋体属细菌的基因组中筛选了候选疫苗的直系同源物。为每个表面暴露蛋白创建了具有高度可信度的三维结构模型。鉴定了主要组织相容性复合体II(MHC - II)表位,并将其位置映射到结构模型上。总共鉴定出18种βb跨膜蛋白和8种OM脂蛋白。这些蛋白在致病性钩端螺旋体属细菌中是保守的,并且预计具有针对几种MHC - II受体变体的表位。对这些表面蛋白序列的结构和功能分析表明,大多数βb跨膜蛋白似乎是与转运相关的依赖TonB的受体。鉴定出的其他蛋白包括例如TolC外排泵蛋白、βb跨膜蛋白组装机制的一种类似BamA的OM组分以及类似LptD的LPS组装蛋白。免疫显性表位的结构映射确定了每个候选疫苗保守的、表面暴露的、免疫原性区域的位置。除了疫苗开发外,目前正在对本研究中鉴定出的蛋白进行评估,以获取它们参与毒力、疾病发病机制和生理学的实验证据。